| |
|
|
|
Aptevo Therapeutics Inc.  
|
|
1.62 0.05 (0.03%) |
01-18 16:00 |
|
Open: |
1.59 |
Pre close: |
1.57 |
Target:
|
2.05
|
|
High: |
1.62 |
Low: |
1.56 |
Resistance:
|
1.75
2.15
|
|
Volume: |
69,910 |
Market Cap: |
37M |
Support:
|
1.11
0.92
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
1.61
 |
MACD |
MACD(12,26):
|
-0.13 |
|
MA(20): |
1.47 |
Signal(12,26,9): |
-0.20 |
|
MA(100): |
3.34  |
Stochastic Oscillator |
%K(14,3):
|
80.00 |
|
MA(250): |
3.92 |
%D(3): |
82.04 |
|
Average Volume(K) |
3-Month: |
10322
|
52-Week |
High:
|
6.35 |
|
10-Days: |
8005 |
Low: |
1.11 |
|
RSI |
RSI(14):
|
43.71 |
Change(%): |
-54.6 |
|
Financials, Statistics and Valuation |
|
EPS |
0.000 |
Return on Equity (ttm) |
-73.4 |
Shares Out. (M) |
22.81 |
|
EPS Est. Current Year |
0.590 |
Return on Assets (ttm) |
-47.0 |
Shares Float (M) |
21.15 |
|
EPS Est. Next Year |
-2.690 |
PEG Ratio |
0.00 |
% Held by Insiders |
7.30 |
|
EPS Est. Next Quarter |
2.250 |
Qtrly Rev. Growth |
-5.6 |
% Held by Institutions |
42.80 |
|
Forward EPS |
-1.321 |
Gross Profit (p.s.) |
0.000 |
Shares Short (K) |
0 |
|
Book Value (p.s.) |
0.830 |
EBITDA (p.s.) |
0.000 |
P/E |
0.00 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
1.95 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-59.55 |
P/S |
41991136.00 |
|
Operating Margin |
-280.95 |
Levered Free Cash Flow
(M) |
-35.76 |
P/CF |
-0.62 |
|
|
|
|
|
|
